Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zejun Bao"'
Publikováno v:
PLoS ONE, Vol 19, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/2b5555a4566a4d77a6babfb766f1babe
Publikováno v:
Academic Journal of Science and Technology. 3:114-118
The cutting teeth on PDC bits have been working under wear for a long time, but the understanding of their rock breaking mechanism is not deep enough. In this paper, the influence of key factors such as wear height, passivation type, invasion depth,
Autor:
Lei Du, Xueyan Zhou, Qian Lu, Zejun Bao, Xiaoxing Yin, Zhenhai Shang, Wei Li, Dongmei Lv, Tao Wang, Feifei Han, Jing Zhu
Publikováno v:
Drug Development Research. 79:129-135
Post-Market Research We aimed to investigate the impact of G protein-coupled receptor kinase 5 (GRK5) rs10886471 polymorphism on repaglinide efficacy in Chinese patients with type 2 diabetes mellitus (T2DM). A total of 300 T2DM patients and 210 healt
Autor:
Juan Wang, Temitope Isaac Adelusi, Mengjun Min, Xiaoxing Yin, Xueyan Zhou, Xiaowen Han, Zejun Bao, Xinyu Li, Hongbin Fan
Publikováno v:
Journal of Neuroscience Research. 96:138-150
Diabetic encephalopathy (DE), one of the most prevalent chronic complications of diabetes mellitus, is short of effective prevention and formidable therapeutic strategies. The aim of the present study is to reveal the imbalance of tryptophan (Trp) an
Autor:
Feng Zhao, Xiaoxing Yin, Xueyan Zhou, Dongmei Lv, Chunxia Chen, Wei Li, Tao Wang, Yingliang Jin, Yun Zhao, Xi Wang, Zejun Bao, Yin Di, Qian Lu
Publikováno v:
Internal Medicine
Objective Previous studies have suggested that variations in the ABCC8 gene may be closely associated with T2DM susceptibility and repaglinide response. However, these results have not been entirely consistent, and there are no related studies in a C
Autor:
Jin-Fang Song, Temitope Isaac Adelusi, Wei Li, Jing Zhu, Zhenhai Shang, Qian Lu, Xiaoxing Yin, Sun Juan, Dongmei Lv, Tao Wang, Xueyan Zhou, Zejun Bao, Yan Wang
Publikováno v:
Scientific Reports
Repaglinide is an insulin secretagogue that often exhibits considerable interindividual variability in therapeutic efficacy. The current study was designed to investigate the impact of KCNQ1 genetic polymorphism on the efficacy of repaglinide and fur